| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/19/2005 | US6881726 Aqueous compositions containing metronidazole |
| 04/19/2005 | US6881724 Use of magnesium (Mg2+) for the preparation of a therapeutic composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy |
| 04/19/2005 | US6881449 Low viscosity, hardenable alginates as film forming; spray coating |
| 04/19/2005 | US6881423 Powdery composition for nasal administration |
| 04/19/2005 | US6881422 Drug for respiratory system disorders |
| 04/19/2005 | US6881421 Nanoparticles comprising at least one polymer and at least one compound able to complex one or more active ingredients |
| 04/19/2005 | US6881420 Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation |
| 04/19/2005 | US6881415 Emulsifier-free finely dispersed water-in-oil type systems |
| 04/19/2005 | US6881403 For prophylaxis and therapy of vaginal infections |
| 04/19/2005 | US6881398 Therapeutic dry powder preparation |
| 04/19/2005 | US6881397 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
| 04/19/2005 | US6881208 Method and device for transdermal electrotransport delivery of fentanyl and sufentanil |
| 04/19/2005 | US6881200 Needleless syringe using super sonic gas flow for particle delivery |
| 04/19/2005 | US6880694 Method and apparatus for transferring substrates |
| 04/19/2005 | CA2295035C Pharmaceutical formulations containing voriconazole |
| 04/19/2005 | CA2150462C Syrup containing n-acetyl-cysteine |
| 04/14/2005 | WO2005033289A2 Transfection reagents |
| 04/14/2005 | WO2005033181A2 Telechelic homopolyamino acids functionalized by hydrophobic groups and uses, particularly therapeutic, thereof |
| 04/14/2005 | WO2005033143A1 Method of stabilizing antibody and stabilized solution-type antibody preparation |
| 04/14/2005 | WO2005032703A1 Device and method for making particles |
| 04/14/2005 | WO2005032593A1 Polyarginine-modified liposome capable of transferring into nucleus |
| 04/14/2005 | WO2005032588A1 Preparation containing basic drug |
| 04/14/2005 | WO2005032577A1 Use of cyclosporin components in ophtalmic conditions |
| 04/14/2005 | WO2005032574A1 Modulation of gastrointestinal epithelium proliferation through the wnt signaling pathway |
| 04/14/2005 | WO2005032555A2 Pharmaceutical combinations of hydrocodone and naltrexone |
| 04/14/2005 | WO2005032554A1 A novel transmucosal delivery system |
| 04/14/2005 | WO2005032553A1 Composition for rapidly disintegrable tablet comprising amlodipine free base |
| 04/14/2005 | WO2005032552A1 Hypnotic composition |
| 04/14/2005 | WO2005032538A1 Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient |
| 04/14/2005 | WO2005032536A1 Drug containing (2r)-2-propyloctanoic acid as the active ingredient |
| 04/14/2005 | WO2005032534A1 Ophthalmic composition for treating lacrimal disorders |
| 04/14/2005 | WO2005032532A1 Antimycotic composition |
| 04/14/2005 | WO2005032531A1 Antimycotic composition |
| 04/14/2005 | WO2005032526A1 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 04/14/2005 | WO2005032525A1 A method for preparing modified release pharmaceutical compositions |
| 04/14/2005 | WO2005032524A2 Osmotically driven active agent delivery device providing an ascending release profile |
| 04/14/2005 | WO2005032523A1 Injectable, oral, or topical sustained release pharmaceutical formulations |
| 04/14/2005 | WO2005032522A1 Topical aerosol foams |
| 04/14/2005 | WO2005032521A2 Non-flammable topical anesthetic liquid aerosols |
| 04/14/2005 | WO2005032520A1 Buccal, polar and non-polar spray containing ondansetron |
| 04/14/2005 | WO2005032519A1 Buccal, polar and non-polar spray containing zolpidem |
| 04/14/2005 | WO2005032518A1 Buccal, polar and non-polar spray containing sumatriptan |
| 04/14/2005 | WO2005032517A1 Buccal, polar and non-polar spray containing diazepam |
| 04/14/2005 | WO2005032516A1 Formulation and manufacturing process of self-microemulsified aceclofenac soft capsules |
| 04/14/2005 | WO2005032515A1 New use, pharmaceutical preparations as well as a process for their production |
| 04/14/2005 | WO2005032514A1 Transdermal pharmaceutical composition |
| 04/14/2005 | WO2005032513A2 Pantoprazole multiparticulate formulations |
| 04/14/2005 | WO2005032512A2 Capsules of multilayered neutral polymer films associated by hydrogen bonding |
| 04/14/2005 | WO2005032511A2 Nanoparticulate therapeutic biologically active agents |
| 04/14/2005 | WO2005032510A1 Triamcinolone acetonide and anecortave acetate formulations for injection |
| 04/14/2005 | WO2005032489A2 Coated metal pyrithione particles for treatment of microorganisms |
| 04/14/2005 | WO2005032483A2 Polysaccharides for pulmonary delivery of active agents |
| 04/14/2005 | WO2005032401A2 Pressure-sensitive adhesive sheet for application to skin |
| 04/14/2005 | WO2005032278A1 SOLUBILIZED CoQ-10 |
| 04/14/2005 | WO2005017180A3 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
| 04/14/2005 | WO2005016275A3 Formulations containing an immune response modifier |
| 04/14/2005 | WO2005011741A3 Delivery of a drug via subconjuctival or periocular delivery of a prodrug in a polymeric microparticle |
| 04/14/2005 | WO2005011641A3 Improved stearate composition and method of production thereof |
| 04/14/2005 | WO2005011639A3 Effervescent pharmaceutical compositions containing vitamin d, calcium and phospate and their therapeutic use |
| 04/14/2005 | WO2005004860A3 Novel solid pharmaceutical composition comprising amisulpride |
| 04/14/2005 | WO2004110408A3 Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol |
| 04/14/2005 | WO2004108061A3 Stable injectable pharmaceutical composition of thiopental; method for stabilizing aqueous solutions of thiopental and, use of thiopental for producing a medicament |
| 04/14/2005 | WO2004096146A3 Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage |
| 04/14/2005 | WO2004094050A3 Sequestered reactive materials |
| 04/14/2005 | WO2004093917A3 Intranasal administration of triptans |
| 04/14/2005 | WO2004091571A3 Polymer coating/encapsulation of nanoparticles using a supercritical antisolvent process |
| 04/14/2005 | WO2004073636A3 Compositions comprising a polysaccharide component and one or more coating layers |
| 04/14/2005 | WO2004071614A3 Method and apparatus for producing particles via supercritical fluid processing |
| 04/14/2005 | WO2004070019A3 Membrane active polymers |
| 04/14/2005 | WO2004058137A3 Compounds for oral dosage of active substances requiring a taste masking |
| 04/14/2005 | WO2003063573A3 Method for treating diseases with omega interferon |
| 04/14/2005 | WO2003051287A3 Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 04/14/2005 | US20050080457 Chronically implantable hybrid cannula-electrode system for continuously monitoring electrophysiological signals during infusion of a chemical or pharmaceutical agent |
| 04/14/2005 | US20050080402 Prevention of myocardial infarction induced ventricular expansion and remodeling |
| 04/14/2005 | US20050080401 Valve port assembly with coincident engagement member for fluid transfer procedures |
| 04/14/2005 | US20050080149 Removable filter for slurry hydrocarbon synthesis process |
| 04/14/2005 | US20050080137 Laxative preparation |
| 04/14/2005 | US20050080136 Spray drying in the presence of trehalose, then granulating and drying; leucine, isoleucine, valine powders; oral meltability and solubility and a high masking effect of the taste |
| 04/14/2005 | US20050080069 comprises Potassium tetrachloroplatinate and lignohumic acid ammonium salts; nontoxic |
| 04/14/2005 | US20050080052 Fine dry powder; rapidly spreads and melts over lung and air passageway surfaces |
| 04/14/2005 | US20050080051 for the treatment of hyperlipidemia and blood coagulation disorders; phosphatidylinositol, phosphatidylserine, phosphatidylglycerol, or phosphatidic acid; dyslipidemia and atherosclerosis |
| 04/14/2005 | US20050080046 In liquid solvent; parenterally administering; aldosterone receptors blockers; congestive heart failure, hypotensive agents, liver disorders |
| 04/14/2005 | US20050080045 topical administration; prevention of STDs preferably a viral disease other than HIV, e.g. HPV or genital herpes and especially acyclovir resistant genital herpes |
| 04/14/2005 | US20050080043 stable without buffer and maintain a stable pH at pH 3.5 or lower |
| 04/14/2005 | US20050080039 Pectin films prepared from gamma irradiated pectin |
| 04/14/2005 | US20050080038 Vaginal pharmaceutical compositions and methods for preparing them |
| 04/14/2005 | US20050080029 Administering to the cell the compound to be delivered, an organic halide, and/or a carrier; ultrasound may also be applied |
| 04/14/2005 | US20050080028 Ballast administering to mammals skins; high density core overcoated with amorphous reservoir containing dna; drug delivery; containing free radical scavenger |
| 04/14/2005 | US20050080009 Storage-stable, liquid fibrinogen formulation |
| 04/14/2005 | US20050080006 Apo2L/TRAIL formulations including lyophilized and crystal compositions; may be used in inducing apoptosis in mammalian cells including cancer cells by exposing mammalian cells to an effective amount of an Apo-2 ligand formulation described herein |
| 04/14/2005 | US20050079597 Antimicrobial composition |
| 04/14/2005 | US20050079545 Method for producing microparticles loaded with proteins |
| 04/14/2005 | US20050079495 Modified membrane protein comprising proteolytic and is absent for g-protein coupling for use as tool in diagnosis, prevention and treatment of pain, arthritis, asthma, psychological and gastrointestinal disorders |
| 04/14/2005 | US20050079264 Tables delivery system |
| 04/14/2005 | US20050079260 Methods for reducing astringency |
| 04/14/2005 | US20050079253 Bilayer edible sheet |
| 04/14/2005 | US20050079245 Addition of a liquid coating syrup to a moving mass of cores for comestibles in a rotating pan and obtaining a plurality of sugar-free hard-coated comestibles having a hard coating on an edible, chewable and/or pharmaceutical core wherein layer of hard coating is directly in contact with core |
| 04/14/2005 | US20050079225 Methods and therapeutic compositions in the treatment of advanced cancer |
| 04/14/2005 | US20050079224 Residual solvent extraction method and microparticles produced thereby |
| 04/14/2005 | US20050079223 Method for obtaining novel lutein-based formulations |